| abstract |
Quinoxaline compounds, compositions, methods of making them, and methods of using them in leukocyte recruitment inhibition, in modulating an H4 receptor, and in treating conditions such as inflammation, H4 receptor-mediated conditions, and related conditions. Formula (I): wherein B is, independently from other member and substituent assignments, N or CR7; Y is independently from other member and substituent assignments, O, S or NH; n is, independently from member and substituent assignments, 1 or 2. |